Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications
The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Abstract
There has been increasing interest in the role of glutamate in mood disorders, especially given the profound effect of the glutamate receptor antagonist ketamine in improving depressive symptoms in patients with treatment-resistant depression. One pathway by which glutamate alterations may occur in mood disorders involves inflammation. Increased inflammation has been observed in a significant subgroup of patients with mood disorders, and inflammatory cytokines have been shown to influence glutamate metabolism through effects on astrocytes and microglia. In addition, the administration of the inflammatory cytokine interferon-alpha has been shown to increase brain glutamate in the basal ganglia and dorsal anterior cingulate cortex as measured by magnetic resonance spectroscopy (MRS). Moreover, MRS studies in patients with major depressive disorder have revealed that increased markers of inflammation including C-reactive protein correlate with increased basal ganglia glutamate, which in turn was associated with anhedonia and psychomotor retardation. Finally, human and laboratory animal studies have shown that the response to glutamate antagonists such as ketamine is predicted by increased inflammatory cytokines. Taken together, these data make a strong case that inflammation may influence glutamate metabolism to alter behavior, leading to depressive symptoms including anhedonia and psychomotor slowing.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inflammation can impact almost all aspects of glutamate neurotransmission (See Haroon and Miller, 2017 for review).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as Haroon and Miller, 2017
In the citing paper
“A recent study reported a 38% prevalence of metabolic syndrome in patients with TRD, and it has been estimated that approximately one-third of depressed patients have elevated inflammatory markers.189”
From Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers (2020) · cites this paper as [189]
In the citing paper
“It has been previously described that inflammation leads to glutamate excitotoxicity and synaptic destruction in depression.189”
From Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers (2020) · cites this paper as [189]
In the citing paper
“A recent study reported a 38% prevalence of metabolic syndrome in patients with TRD, and it has been estimated that approximately one-third of depressed patients have elevated inflammatory markers.189”
From Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers (2020) · cites this paper as [189]
Citations
Cites
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942
Self-citationInflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
Self-citationAssociations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
Ankarcrona, M., Dypbukt, J. M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., Lipton, S. A., & Nicotera, P. (1995) · Neuron · doi:10.1016/0896-6273(95)90186-8 · Cited by 1,884
Astrocytes, from brain glue to communication elements: the revolution continues
Volterra, A., & Meldolesi, J. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1722 · Cited by 1,770
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
Hardingham, G. E., & Bading, H. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2911 · Cited by 1,644
Beyond oxidative stress: an immunologist's guide to reactive oxygen species
Nathan, C., & Cunningham-Bussel, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3423 · Cited by 1,619
Kynurenines in the mammalian brain: when physiology meets pathology
Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3257 · Cited by 1,530
Immune modulation of learning, memory, neural plasticity and neurogenesis
Yirmiya, R., & Goshen, I. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.015 · Cited by 1,483
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477
The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission
Popoli, M., Yan, Z., McEwen, B. S., & Sanacora, G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3138 · Cited by 1,393
Haapakoski, R., Mathieu, J., Ebmeier, K. P., Alenius, H., & Kivimäki, M. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.06.001 · Cited by 1,129
Bezzi, P., Domercq, M., Brambilla, L., Galli, R., Schols, D., De Clercq, E., Vescovi, A., Bagetta, G., Kollias, G., Meldolesi, J., et al. (2001) · Nature Neuroscience · doi:10.1038/89490 · Cited by 1,102
Mood disorders in the medically ill: scientific review and recommendations
Evans, D. L., Charney, D. S., Lewis, L., Golden, R. N., Gorman, J. M., Krishnan, K. R. R., Nemeroff, C. B., Bremner, J. D., Carney, R. M., Coyne, J. C., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.001 · Cited by 1,071
Self-citationGlutamate as a neurotransmitter in the healthy brain
Zhou, Y., & Danbolt, N. C. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1180-8 · Cited by 979
Lewerenz, J., Hewett, S. J., Huang, Y., Lambros, M., Gout, P. W., Kalivas, P. W., Massie, A., Smolders, I., Methner, A., Pergande, M., et al. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4391 · Cited by 978
Depression as a Microglial Disease
Yirmiya, R., Rimmerman, N., & Reshef, R. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.001 · Cited by 944
Köhler, O., Benros, M. E., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., Mors, O., & Krogh, J. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1611 · Cited by 941
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Sanacora, G., Zarate, C. A., Krystal, J. H., & Manji, H. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2462 · Cited by 894
The tripartite synapse: roles for gliotransmission in health and disease
Halassa, M. M., Fellin, T., & Haydon, P. G. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.12.005 · Cited by 852
Capuron, L. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00407-9 · Cited by 797
Self-citationMüller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Müller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001805 · Cited by 794
Harrison, N. A., Brydon, L., Walker, C., Gray, M. A., Steptoe, A., & Critchley, H. D. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.03.015 · Cited by 756
Cytokine Production and Treatment Response in Major Depressive Disorder
Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735
Inflammation-associated depression: From serotonin to kynurenine
Dantzer, R., O’Connor, J. C., Lawson, M. A., & Kelley, K. W. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.09.012 · Cited by 726
Chronic Glutamate Toxicity in Neurodegenerative Diseases—What is the Evidence?
Lewerenz, J., & Maher, P. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00469 · Cited by 718
Inflammation and clinical response to treatment in depression: A meta-analysis
Strawbridge, R., Arnone, D., Danese, A., Papadopoulos, A., Herane Vives, A., & Cleare, A. J. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.06.007 · Cited by 666
Choudary, P. V., Molnar, M., Evans, S. J., Tomita, H., Li, J. Z., Vawter, M. P., Myers, R. M., Bunney, W. E., Akil, H., Watson, S. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507901102 · Cited by 652
Kynurenines in the CNS: recent advances and new questions
Vécsei, L., Szalárdy, L., Fülöp, F., & Toldi, J. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3793 · Cited by 641
Raison, C. L., Dantzer, R., Kelley, K. W., Lawson, M. A., Woolwine, B. J., Vogt, G., Spivey, J. R., Saito, K., & Miller, A. H. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.116 · Cited by 630
Self-citationGliogenesis and Glial Pathology in Depression
Rajkowska, G., & Miguel-Hidalgo, J. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707780619326 · Cited by 610
Astrocyte Pathology in Major Depressive Disorder: Insights from Human Postmortem Brain Tissue
Rajkowska, G., & Stockmeier, C. (2013) · Current Drug Targets · doi:10.2174/13894501113149990156 · Cited by 603
Inflammation-Induced Anhedonia: Endotoxin Reduces Ventral Striatum Responses to Reward
Eisenberger, N. I., Berkman, E. T., Inagaki, T. K., Rameson, L. T., Mashal, N. M., & Irwin, M. R. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.010 · Cited by 596
Neuroimmune mechanisms of depression
Hodes, G. E., Kana, V., Menard, C., Merad, M., & Russo, S. J. (2015) · Nature Neuroscience · doi:10.1038/nn.4113 · Cited by 585
Manipulation of Brain Kynurenines: Glial Targets, Neuronal Effects, and Clinical Opportunities
Schwarcz, R., & Pellicciari, R. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034439 · Cited by 556
Synaptic Activation of Glutamate Transporters in Hippocampal Astrocytes
Bergles, D. E., & Jahr, C. E. (1997) · Neuron · doi:10.1016/s0896-6273(00)80420-1 · Cited by 516
Interferon-alpha–induced changes in tryptophan metabolism
Capuron, L., Neurauter, G., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., Fuchs, D., & Miller, A. H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00173-2 · Cited by 493
Self-citationMagnetic Resonance Spectroscopy Studies of Glutamate-Related Abnormalities in Mood Disorders
Yüksel, C., & Öngür, D. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.016 · Cited by 493
P2X 7 Receptor-Mediated Release of Excitatory Amino Acids from Astrocytes
Duan, S., Anderson, C. M., Keung, E. C., Chen, Y., Chen, Y., & Swanson, R. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01320.2003 · Cited by 489
Lener, M. S., Niciu, M. J., Ballard, E. D., Park, M., Park, L. T., Nugent, A. C., & Zarate, C. A. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.05.005 · Cited by 468
Beyond the role of glutamate as a neurotransmitter
Nedergaard, M., Takano, T., & Hansen, A. J. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn916 · Cited by 450
Cattaneo, A., Gennarelli, M., Uher, R., Breen, G., Farmer, A., Aitchison, K. J., Craig, I. W., Anacker, C., Zunsztain, P. A., McGuffin, P., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.191 · Cited by 436
Walker, A. K., Budac, D. P., Bisulco, S., Lee, A. W., Smith, R. A., Beenders, B., Kelley, K. W., & Dantzer, R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.71 · Cited by 432
Neural sensitivity to social rejection is associated with inflammatory responses to social stress
Slavich, G. M., Way, B. M., Eisenberger, N. I., & Taylor, S. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009164107 · Cited by 418
Eisenberger, N. I., Inagaki, T. K., Mashal, N. M., & Irwin, M. R. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.12.009 · Cited by 413
1H MR Spectroscopy of the Brain: Absolute Quantification of Metabolites
Jansen, J. F. A., Backes, W. H., Nicolay, K., & Kooi, M. E. (2006) · Radiology · doi:10.1148/radiol.2402050314 · Cited by 405
Stagg, C. J., Bestmann, S., Constantinescu, A. O., Moreno Moreno, L., Allman, C., Mekle, R., Woolrich, M., Near, J., Johansen‐Berg, H., & Rothwell, J. C. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.216978 · Cited by 401
Interleukin-1 (IL-1): A central regulator of stress responses
Goshen, I., & Yirmiya, R. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.10.001 · Cited by 399
Akhondzadeh, S., Jafari, S., Raisi, F., Nasehi, A. A., Ghoreishi, A., Salehi, B., Mohebbi-Rasa, S., Raznahan, M., & Kamalipour, A. (2009) · Depression and Anxiety · doi:10.1002/da.20589 · Cited by 397
Sequeira, A., Mamdani, F., Ernst, C., Vawter, M. P., Bunney, W. E., Lebel, V., Rehal, S., Klempan, T., Gratton, A., Benkelfat, C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006585 · Cited by 388
Iwata, M., Ota, K. T., Li, X.-Y., Sakaue, F., Li, N., Dutheil, S., Banasr, M., Duric, V., Yamanashi, T., Kaneko, K., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.026 · Cited by 387
Capuron, L., Pagnoni, G., Drake, D. F., Woolwine, B. J., Spivey, J. R., Crowe, R. J., Votaw, J. R., Goodman, M. M., & Miller, A. H. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2094 · Cited by 382
Self-citationNeuroinflammation and regulation of glial glutamate uptake in neurological disorders
Tilleux, S., & Hermans, E. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21325 · Cited by 381
Bernard, R., Kerman, I. A., Thompson, R. C., Jones, E. G., Bunney, W. E., Barchas, J. D., Schatzberg, A. F., Myers, R. M., Akil, H., & Watson, S. J. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.44 · Cited by 372
Is There a Cerebral Lymphatic System?
Iliff, J. J., & Nedergaard, M. (2013) · Stroke · doi:10.1161/strokeaha.112.678698 · Cited by 364
Mechanisms of glutamate release from astrocytes
Malarkey, E. B., & Parpura, V. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2007.06.005 · Cited by 356
Connecting inflammation with glutamate agonism in suicidality
Erhardt, S., Lim, C. K., Linderholm, K. R., Janelidze, S., Lindqvist, D., Samuelsson, M., Lundberg, K., Postolache, T. T., Träskman-Bendz, L., Guillemin, G. J., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.248 · Cited by 345
Abbasi, S.-H., Hosseini, F., Modabbernia, A., Ashrafi, M., & Akhondzadeh, S. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.03.033 · Cited by 339
Inhibition of uptake unmasks rapid extracellular turnover of glutamate of nonvesicular origin
Jabaudon, D., Shimamoto, K., Yasuda-Kamatani, Y., Scanziani, M., Gähwiler, B. H., & Gerber, U. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8733 · Cited by 305
Astrocytic abnormalities and global DNA methylation patterns in depression and suicide
Nagy, C., Suderman, M., Yang, J., Szyf, M., Mechawar, N., Ernst, C., & Turecki, G. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.21 · Cited by 301
Pfleiderer, B., Michael, N., Erfurth, A., Ohrmann, P., Hohmann, U., Wolgast, M., Fiebich, M., Arolt, V., & Heindel, W. (2003) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(03)00003-9 · Cited by 301
Savitz, J., Drevets, W. C., Smith, C. M., Victor, T. A., Wurfel, B. E., Bellgowan, P. S., Bodurka, J., Teague, T. K., & Dantzer, R. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.194 · Cited by 272
Astroglial cradle in the life of the synapse
Verkhratsky, A., & Nedergaard, M. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0595 · Cited by 266
The kynurenine pathway of tryptophan degradation as a drug target
Schwarcz, R. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.10.006 · Cited by 265
MICHAEL, N., ERFURTH, A., OHRMANN, P., AROLT, V., HEINDEL, W., & PFLEIDERER, B. (2003) · Psychological Medicine · doi:10.1017/s0033291703007931 · Cited by 260
Haroon, E., Fleischer, C. C., Felger, J. C., Chen, X., Woolwine, B. J., Patel, T., Hu, X. P., & Miller, A. H. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.206 · Cited by 250
Self-citationDuman, R. S. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.1/rduman · Cited by 249
Positive and negative regulation of EAAT2 by NF‐κB: a role for N‐myc in TNFα‐controlled repression
Sitcheran, R., Gupta, P., Fisher, P. B., & Baldwin, A. S. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600555 · Cited by 240
Luykx, J. J., Laban, K. G., van den Heuvel, M. P., Boks, M. P. M., Mandl, R. C. W., Kahn, R. S., & Bakker, S. C. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.05.014 · Cited by 235
Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: A meta-analysis
Yildiz-Yesiloglu, A., & Ankerst, D. P. (2006) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2005.12.004 · Cited by 232
Acute decrease in net glutamate uptake during energy deprivation
Jabaudon, D., Scanziani, M., Gähwiler, B. H., & Gerber, U. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5610 · Cited by 231
Basal Ganglia Hypermetabolism and Symptoms of Fatigue during Interferon-α Therapy
Capuron, L., Pagnoni, G., Demetrashvili, M. F., Lawson, D. H., Fornwalt, F. B., Woolwine, B., Berns, G. S., Nemeroff, C. B., & Miller, A. H. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301362 · Cited by 229
Self-citationGlutamatergic Modulators: The Future of Treating Mood Disorders?
Zarate, C., Machado-Vieira, R., Henter, I., Ibrahim, L., Diazgranados, N., & Salvadore, G. (2010) · Harvard Review of Psychiatry · doi:10.3109/10673229.2010.511059 · Cited by 228
Bufalino, C., Hepgul, N., Aguglia, E., & Pariante, C. M. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.04.009 · Cited by 228
Gigante, A. D., Bond, D. J., Lafer, B., Lam, R. W., Young, L. T., & Yatham, L. N. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.01033.x · Cited by 226
Age and neuroinflammation: a lifetime of psychoneuroimmune consequences
Godbout, J. P., & Johnson, R. W. (2009) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2009.02.007 · Cited by 224
Astrocytic Hypertrophy in Anterior Cingulate White Matter of Depressed Suicides
Torres-Platas, S. G., Hercher, C., Davoli, M. A., Maussion, G., Labonté, B., Turecki, G., & Mechawar, N. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.154 · Cited by 223
Anterior Cingulate Activation and Error Processing During Interferon-Alpha Treatment
Capuron, L., Pagnoni, G., Demetrashvili, M., Woolwine, B. J., Nemeroff, C. B., Berns, G. S., & Miller, A. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.033 · Cited by 222
Self-citationCytokine modulation of glial glutamate uptake: a possble involvement of nitric oxide
Ye, Z.-C., & Sontheimer, H. (1996) · NeuroReport · doi:10.1097/00001756-199609020-00025 · Cited by 211
Valentine, G. W., Mason, G. F., Gomez, R., Fasula, M., Watzl, J., Pittman, B., Krystal, J. H., & Sanacora, G. (2011) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2010.10.009 · Cited by 204
Yang, J.-J., Wang, N., Yang, C., Shi, J.-Y., Yu, H.-Y., & Hashimoto, K. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.06.021 · Cited by 202
Glutamate Metabolism in Major Depressive Disorder
Abdallah, C. G., Jiang, L., De Feyter, H. M., Fasula, M., Krystal, J. H., Rothman, D. L., Mason, G. F., & Sanacora, G. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14010067 · Cited by 200
Vercellino, M., Merola, A., Piacentino, C., Votta, B., Capello, E., Mancardi, G. L., Mutani, R., Giordana, M. T., & Cavalla, P. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31812571b0 · Cited by 190
A neurocomputational account of how inflammation enhances sensitivity to punishments versus rewards
Harrison, N. A., Voon, V., Cercignani, M., Cooper, E. A., Pessiglione, M., & Critchley, H. D. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.018 · Cited by 185
Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder
Niciu, M. J., Ionescu, D. F., Richards, E. M., & Zarate, C. A. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1130-x · Cited by 177
Felger, J. C., Li, L., Marvar, P. J., Woolwine, B. J., Harrison, D. G., Raison, C. L., & Miller, A. H. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.10.010 · Cited by 176
Self-citationNa, K.-S., Lee, K. J., Lee, J. S., Cho, Y. S., & Jung, H.-Y. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.09.006 · Cited by 176
Persson, M., Brantefjord, M., Hansson, E., & Rönnbäck, L. (2005) · Glia · doi:10.1002/glia.20191 · Cited by 176
Meier, T. B., Drevets, W. C., Wurfel, B. E., Ford, B. N., Morris, H. M., Victor, T. A., Bodurka, J., Teague, T. K., Dantzer, R., & Savitz, J. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.11.003 · Cited by 175
Rothstein, J. D. (1996) · Neurology · doi:10.1212/wnl.47.4_suppl_2.19s · Cited by 174
Takaki, J., Fujimori, K., Miura, M., Suzuki, T., Sekino, Y., & Sato, K. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-275 · Cited by 173
The role of inflammation in suicidal behaviour
Brundin, L., Erhardt, S., Bryleva, E. Y., Achtyes, E. D., & Postolache, T. T. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12458 · Cited by 172
Bechtholt, A. J., Walther, H. V., Adams, M. A., Carlezon, W. A., Öngür, D., & Cohen, B. M. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.74 · Cited by 172
Barley, K. M., Dracheva, S. M., & Byne, W. M. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.04.019 · Cited by 171
Constant, A., Castéra, L., Dantzer, R., Couzigou, P., de Lédinghen, V., Demotes‐Mainard, J., & Henry, C. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0814 · Cited by 170
Ernst, C., Mechawar, N., & Turecki, G. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.09.001 · Cited by 158
Haroon, E., Woolwine, B. J., Chen, X., Pace, T. W., Parekh, S., Spivey, J. R., Hu, X. P., & Miller, A. H. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.25 · Cited by 154
Self-citationTremblay, S., Beaulé, V., Proulx, S., Beaumont, L. D., Marjańska, M., Doyon, J., Pascual‐Leone, Á., Lassonde, M. C., & Théoret, H. (2012) · Journal of Neurophysiology · doi:10.1152/jn.00704.2012 · Cited by 151
Arnone, D., Mumuni, A. N., Jauhar, S., Condon, B., & Cavanagh, J. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.04.016 · Cited by 150
Tricarboxylic acid cycle of glia in the in vivo human brain
Blüml, S., Moreno‐Torres, A., Shic, F., Nguy, C. ‐., & Ross, B. D. (2002) · NMR in Biomedicine · doi:10.1002/nbm.725 · Cited by 150
Altered expression of glutamate transporters in experimental autoimmune encephalomyelitis
Ohgoh, M. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00029-2 · Cited by 143
Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression?
Dantzer, R., & Walker, A. K. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1187-1 · Cited by 136
Sluzewska, A., Sobieska, M., & Rybakowski, J. K. (2008) · Neuropsychobiology · doi:10.1159/000119332 · Cited by 134
Savitz, J., Dantzer, R., Wurfel, B. E., Victor, T. A., Ford, B. N., Bodurka, J., Bellgowan, P. S. F., Teague, T. K., & Drevets, W. C. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.11.015 · Cited by 133
Kynurenine pathway inhibition as a therapeutic strategy for neuroprotection
Stone, T. W., Forrest, C. M., & Darlington, L. G. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08487.x · Cited by 130
Korn, T., Magnus, T., & Jung, S. (2005) · The FASEB Journal · doi:10.1096/fj.05-3748fje · Cited by 127
Fleshner, M. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.08.012 · Cited by 126
The role of adipokines in the rapid antidepressant effects of ketamine
Machado-Vieira, R., Gold, P. W., Luckenbaugh, D. A., Ballard, E. D., Richards, E. M., Henter, I. D., De Sousa, R. T., Niciu, M. J., Yuan, P., & Zarate, C. A. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.36 · Cited by 102
Miller, A. H., & Raison, C. L. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.22 · Cited by 101
Self-citationZhang, C., Li, Z., Wu, Z., Chen, J., Wang, Z., Peng, D., Hong, W., Yuan, C., Wang, Z., Yu, S., et al. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3297-0 · Cited by 99
Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder
Savitz, J., Dantzer, R., Meier, T. B., Wurfel, B. E., Victor, T. A., McIntosh, S. A., Ford, B. N., Morris, H. M., Bodurka, J., Teague, T. K., et al. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.07.609 · Cited by 94
Blood Glutamate Scavenging: Insight into Neuroprotection
Leibowitz, A., Boyko, M., Shapira, Y., & Zlotnik, A. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130810041 · Cited by 92
Schwarcz, R. M. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2016.01.005 · Cited by 90
Faridhosseini, F., Sadeghi, R., Farid, L., & Pourgholami, M. (2014) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2401 · Cited by 89
Szymocha, R., Akaoka, H., Dutuit, M., Malcus, C., Didier-Bazes, M., Belin, M.-F., & Giraudon, P. (2000) · Journal of Virology · doi:10.1128/jvi.74.14.6433-6441.2000 · Cited by 83
Quinolinic acid: neurotoxicity
Guillemin, G. J. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08493.x · Cited by 83
Wang, F., Smith, N., Xu, Q., Goldman, S., Peng, W., Huang, J. H., Takano, T., & Nedergaard, M. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2178-13.2013 · Cited by 75
Glutamate normalization with ECT treatment response in major depression
Zhang, J., Narr, K. L., Woods, R. P., Phillips, O. R., Alger, J. R., & Espinoza, R. T. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.46 · Cited by 73
Novel insights into gliotransmitters
Petrelli, F., & Bezzi, P. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.11.010 · Cited by 71
Glutamate Receptors in Microglia
Murugan, M., Ling, E.-A., & Kaur, C. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660174 · Cited by 67
Haroon, E., Felger, J. C., Woolwine, B. J., Chen, X., Parekh, S., Spivey, J. R., Hu, X. P., & Miller, A. H. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.12.004 · Cited by 66
Self-citationMR spectroscopy: its potential role for drug development for the treatment of psychiatric diseases
Mason, G. F., & Krystal, J. H. (2006) · NMR in Biomedicine · doi:10.1002/nbm.1080 · Cited by 60
Walker, A. J., Foley, B. M., Sutor, S. L., McGillivray, J. A., Frye, M. A., & Tye, S. J. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.07.026 · Cited by 56
Review: Magnetic Resonance Spectroscopy Studies of Pediatric Major Depressive Disorder
Kondo, D. G., Hellem, T., Sung, Y., Kim, N., Jeong, E.-K., Delmastro, K. K., Shi, X., & Renshaw, P. F. (2010) · Depression Research and Treatment · doi:10.1155/2011/650450 · Cited by 53
EAAT expression by macrophages and microglia: still more questions than answers
Gras, G., Samah, B., Hubert, A., Léone, C., Porcheray, F., & Rimaniol, A. (2011) · Amino Acids · doi:10.1007/s00726-011-0866-6 · Cited by 49
Taylor, M. J., Murphy, S. E., Selvaraj, S., Wylezinkska, M., Jezzard, P., Cowen, P. J., & Evans, J. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107081510 · Cited by 44
Murck, H., Schubert, M. I., Schmid, D. A., SCHÜSSLER, P., Steiger, A., & Auer, D. P. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.04.009 · Cited by 44
Astroglial amino acid-based transmitter receptors
Parpura, V., & Verkhratsky, A. (2013) · Amino Acids · doi:10.1007/s00726-013-1458-4 · Cited by 39
Glial Abnormalities in Mood Disorders
Öngür, D., Bechtholt, A. J., Carlezon, W. A., & Cohen, B. M. (2014) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000060 · Cited by 34
Moore, C. M., Frederick, B. B., & Renshaw, P. F. (1999) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879901200304 · Cited by 21
Inflammation and treatment resistance in major depression: The perfect storm
Raison, C. L., Felger, J. C., & Miller, A. H. (2013) · The Psychiatric times · Cited by 21
Self-citation314. Brain chemistry in pediatric depression
Rosenberg, D. R., Paulson, L. D., Seraji‐Bozorgzad, N., Wilds, I. B., STEWART, C., & Moore, G. J. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00578-3 · Cited by 9
Research works printed but not linked: 2
- CDC (2015) Suicide - facts at a glance 2015. Centers for Disease Control, Atlanta, GA, USA
- Hashemian F, Majd M, Hosseini SM, Sharifi A, Panahi MVS, Bigdeli O (2011) A randomized, double-blind, placebo-controlled trial of celecoxib augmentation of sertraline in the treatment of a drug-naive women with major depression. Klinik Psikofarmakoloji Bulteni 21:S183–S184
Cited by
Recognizing Depression from the Microbiota–Gut–Brain Axis
Liang, S., Wu, X., Hu, X., Wang, T., & Jin, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061592 · Cited by 380
Immune targets for therapeutic development in depression: towards precision medicine
Drevets, W. C., Wittenberg, G. M., Bullmore, E. T., & Manji, H. K. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00368-1 · Cited by 348
Rosenblat, J., & McIntyre, R. (2017) · Brain Sciences · doi:10.3390/brainsci7110144 · Cited by 258
Matveychuk, D., Thomas, R. K., Swainson, J., Khullar, A., MacKay, M.-A., Baker, G. B., & Dursun, S. M. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320916657 · Cited by 209
Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide
Duman, R. S. (2018) · F1000Research · doi:10.12688/f1000research.14344.1 · Cited by 207
Metadata
- Authors
- Haroon, E., & Miller, A. H.
- Affiliations
- Emory University (US)
- Corresponding author
- Miller, Andrew H.
- Venue
- Current Topics in Behavioral Neurosciences
- Publisher
- Springer International Publishing
- Published
- 2016
- Volume
- 31
- Pages
- 173-198
- ISSN
- 1866-3370 (ISSN-L)
- 1866-3389
- OpenAlex
- W2552532188
- Cited by
- 153
- References
- 137
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 18 · 2023: 17 · 2022: 19 · 2021: 21 · 2020: 17 · 2019: 15 · 2018: 16 · 2017: 5 · 2016: 2
- FWCI
- 2.77
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Current topics in behavioral neurosciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (UL1TR000454)
- National Institute of Mental Health (R21MH077172, R01MH112076, R03MH100273, R01MH107033, R01MH087604, K23MH091254, R21MH105897)
- National Cancer Institute (P30CA138292)
- National Center for Research Resources (UL1RR025008)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- brain glutamate, inflammation, depression, major depressive disorder, inflammatory cytokines, ketamine, treatment-resistant depression, astrocytes, microglia, interferon-alpha, C-reactive protein, basal ganglia, dorsal anterior cingulate cortex, anhedonia, psychomotor retardation, glutamate metabolism
- MeSH terms
- Animals, Depression, Humans, Inflammation, Excitatory Amino Acid Antagonists, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.